30 Day FDA and ICH Drug Development Regulations - Day 21 Biologics and Biosimilars

from Cannabinoid and Psychedelic Pharmacology and Drug Development

Dive into the intricate world of biologics and biosimilars in this episode as we unravel the science, regulations, and real-world impact of these groundbreaking therapies. From their unique manufacturing challenges and complex molecular structures to the rigorous clinical trials and approval pathways, we explore what makes biologics the pinnacle of medical innovation. Learn how biosimilars are paving the way for more affordable and accessible treatments, their potential to transform healthcare, and the evolving dynamics of innovation and affordability. Join us for an insightful journey into the future of medicine.

NOW PLAYING

0:00 19:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 19 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 29, 2025.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!